A panel at the US Centers for Disease Control has said it needs more time to assess the risks of the Johnson and Johnson COVID-19 vaccine.
Administration of the one-shot vaccine has been paused while possible links to an extremely small number of rare blood clots are investigated.
US correspondent Ira Spitzer has more
IN: The advisory panel...